Sep 12, 2014

FDA approves weight-loss drug Contrave

U.S. regulators are greenlighting a new weight-loss drug called Contrave, the third in a string of approvals for anti-obesity treatments. The drug was developed by Orexigen Therapeutics Inc., based in La Jolla, California. The Food and Drug Administration said Thursday that it is approved ...

New COO pledges to take Takeda to the top

Apr 2, 2014

New COO pledges to take Takeda to the top

Christophe Weber, the new chief operating officer of Takeda Pharmaceutical Co., said Wednesday he aims to make the company the world’s leading drugmaker by drawing on his more than two decades of business experience at GlaxoSmithKline. He said his ambition for Takeda is “being ...